johnson & johnson - Search News

Johnson & Johnson, Stroke and Cerenovus

Johnson & Johnson (JNJ) Plans $1 Billion Sale of ‘Cerenovus’ Stroke Unit

Pharmaceutical giant Johnson & Johnson (JNJ) is planning to sell its stroke care business called “Cerenovus” for $1 billion or more.

Benzinga.com · 2d

Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ongoing efforts to refine its medtech division.

The Financial Times · 3d

Johnson & Johnson puts stroke care business up for sale

Johnson & Johnson has put its stroke care business up for sale, aiming for a valuation of more than $1bn, as part of its efforts to reorganise its medical technology division, according to people familiar with the matter.

Johnson & Johnson halts late-stage E.coli vaccine trial

New York Post on MSN · 1d

Johnson & Johnson halts late-stage E.coli vaccine trial after poor results

Johnson & Johnson and Sanofi said that while the vaccine showed no safety concerns, it did not meet the necessary effectiveness thresholds.

Reuters on MSN · 1d

J&J, Sanofi stop E.coli vaccine trial due to low effectiveness

Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by the E.coli bacteria due to a lack of sufficient efficacy, the companies said on Thursday.

GlobalData on MSN · 1d

J&J stops Phase III trial of Sanofi’s E. Coli vaccine citing ‘disappointing’ results

The company said it will stop the Phase III trial of ExPEC after interim results found it failed to demonstrate efficacy over placebo.

NASCAR, Jimmie Johnson

U.S. News & World Report · 1d

Jimmie Johnson Scuffled in His First 2 Years as NASCAR Team Owner. Can He Make Legacy a Winner?

Justin Allgaier, left, and Jimmie Johnson talk on the pit road during qualifying for the NASCAR Daytona 500 auto race at Daytona International Speedway, Wednesday, Feb. 12, 2025, in Daytona Beach, Fla.

NBC Sports · 1d

New NASCAR rule could impact Jimmie Johnson’s chances of making Daytona 500

Jimmie Johnson said he was not happy when he found out about NASCAR's new provisional and that he wouldn't be eligible for it at Daytona.

St. Louis Post-Dispatch · 20h

In year 3 as NASCAR team owner, Johnson aims high for Legacy

The vision of his true NASCAR future crystalized for Jimmie Johnson at last year's season finale. He climbed into his Toyota at Phoenix for his ninth, nondescript race of the season when he spotted them on pit road,

Rory McIlroy is alienating players on PGA TOUR

Golfweek on MSN · 17h

An angry Johnson Wagner pops off at Rory McIlroy after recent comments

Rory McIlroy's comments that players should "get over" their hard feelings about reunifying men's pro golf didn't sit well with GC's Johnson Wagner.

Golf Digest on MSN · 6h

Johnson Wagner rebukes Rory McIlroy over LIV-PGA Tour comments: 'He's angering me right now'

Johnson Wagner has gained notoriety and fame in the past year by recreating golf shots on air, but on Thursday he took a different kind of shot at one of the game's biggest stars. During a Golf Channel segment,

Golf on MSN · 2h

'He's trying to get his way:' Pro fires back at Rory McIlroy over latest PGA Tour-LIV comments

Johnson Wagner fired back at Rory McIlroy after the four-time major champion's latest comments on the PGA Tour-LIV negotiations. The post ‘He’s trying to get his way:’ Pro fires back at Rory McIlroy over latest PGA Tour-LIV comments appeared first on Golf.

Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study

Sanofi and J&J halted a phase 3 E. coli vaccine trial due to insufficient efficacy. Sanofi's Q4 2024 IFRS EPS dropped by ...

3hon MSN

Jim Cramer on Johnson & Johnson (JNJ): ‘Too Slow Growing’

We recently compiled a list of the Jim Cramer Discussed These 11 Stocks Recently. In this article, we are going to take a ...

1don MSN

Johnson & Johnson reports progress on nipocalimab

HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...

11hon MSN

Johnson & Johnson Launches New Intraocular Lens TECNIS PureSee™ in India

Johnson & Johnson has launched the TECNIS PureSee™ intraocular lens in India, catering to individuals with presbyopia. The ...

'The evidence is overwhelming': NZ class action against Johnson and Johnson follows similar suits worldwide

A class action lawsuit launched in Auckland today questioning Johnson and Johnson cold and flu products follows similar suits ...

2don MSN

Johnson & Johnson aims to sell Cerenovus for over $1 billion - Financial Times

Johnson & Johnson (NYSE:JNJ), the New Jersey-based healthcare company, is planning to sell its stroke care business, ...

1don MSN

Johnson & Johnson: NZ class action launched over cold and flu medicine product

The lawsuit says Kiwis have been deceived for about two decades about an ingredient in cold and flu medicine.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Johnson & Johnson, Stroke and Cerenovus

Johnson & Johnson halts late-stage E.coli vaccine trial

NASCAR, Jimmie Johnson

Rory McIlroy is alienating players on PGA TOUR

Related topics